Safety and Efficiency of the Universal CNK-UT009 in Difficult-to-treat Inflammatory Bowel Disease Patients

NCT07416383 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Inflamatory Bowel Disease
Crohn Disease (CD)
Ulcerative Colitis (UC)

Interventions

DRUG: injection of CNK-UT009

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University